Combined behavioral therapy and pharmacotherapy of agoraphobia
- PMID: 7908332
- DOI: 10.1016/0022-3956(93)90027-y
Combined behavioral therapy and pharmacotherapy of agoraphobia
Abstract
There are few controlled studies of combined behavioral-pharmacological treatments of agoraphobia with panic. This review of the empirical evidence from studies using exposure in vivo as the behavioral modality and imipramine as the pharmacological agent suggests that these treatments have mutually potentiating effects in this disorder.
Similar articles
-
Treatment of panic disorder with agoraphobia: randomized placebo-controlled trial of four psychosocial treatments combined with imipramine or placebo.Cogn Behav Ther. 2008;37(3):146-59. doi: 10.1080/16506070701743120. Cogn Behav Ther. 2008. PMID: 18608313 Clinical Trial.
-
Combined pharmacological and behavioral treatment for agoraphobia.Behav Res Ther. 1985;23(3):325-35. doi: 10.1016/0005-7967(85)90011-7. Behav Res Ther. 1985. PMID: 2860892 Clinical Trial. No abstract available.
-
Panic and avoidance in agoraphobia. Application of path analysis to treatment studies.Arch Gen Psychiatry. 1987 Apr;44(4):377-85. doi: 10.1001/archpsyc.1987.01800160093011. Arch Gen Psychiatry. 1987. PMID: 2882736 Clinical Trial.
-
Differential effects of imipramine and behavior therapy on panic disorder with agoraphobia.Psychopharmacol Bull. 1989;25(1):27-9. Psychopharmacol Bull. 1989. PMID: 2672069 Review. No abstract available.
-
Antidepressant medication in the treatment of agoraphobia: a critical review.Behav Res Ther. 1983;21(5):505-17. doi: 10.1016/0005-7967(83)90042-6. Behav Res Ther. 1983. PMID: 6140001 Review. No abstract available.
Cited by
-
Combined psychotherapy plus antidepressants for panic disorder with or without agoraphobia.Cochrane Database Syst Rev. 2007 Jan 24;2007(1):CD004364. doi: 10.1002/14651858.CD004364.pub2. Cochrane Database Syst Rev. 2007. PMID: 17253502 Free PMC article.